SKI Market

Indian Indices

Sensex

81,909.63 -270.84
( -0.33%)

Global Indices

Nasdaq

48,505.62 -874.72
(-1.77%)

Dow Jones

6,816.34 -144.67
(-2.08%)

Hang Seng

52,693.20 -297.90
(-0.56%)

Nikkei 225

10,111.70 -83.65
(-0.82%)

Forex

USD-INR

90.86 0.32
(0.35%)

EUR-INR

105.69 0.68
(0.65%)

GBP-INR

121.83 0.75
(0.62%)

JPY-INR

0.58 0.00
(0.45%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Shilpa Medicare Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

530549

INE790G01031

137.4709721

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SHILPAMED

49.65

5447.93

EPS(TTM)

Face Value()

Div & Yield %

5.61

0.18

Back

Jubilant Ingrevia consolidated net profit rises 17.75% in the September 2025 quarter

Oct 27,2025

Net profit of Jubilant Ingrevia rose 17.75% to Rs 69.47 crore in the quarter ended September 2025 as against Rs 59.00 crore during the previous quarter ended September 2024. Sales rose 7.84% to Rs 1109.66 crore in the quarter ended September 2025 as against Rs 1029.00 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1109.66	1029.00	8
OPM %	12.21	12.09	-
PBDT	134.09	119.82	12
PBT	92.86	80.22	16
NP	69.47	59.00	18

81,909.63 -270.84 ( -0.33%)

48,505.62 -874.72 (-1.77%)

6,816.34 -144.67 (-2.08%)

52,693.20 -297.90 (-0.56%)

10,111.70 -83.65 (-0.82%)

90.86 0.32 (0.35%)

105.69 0.68 (0.65%)

121.83 0.75 (0.62%)

0.58 0.00 (0.45%)